The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

Real-Time Drug Safety Analysis with Evidex Alerts

Posted by Bob Kyle on Jan 20, 2017 10:30:00 AM

This week we launched Evidex Alerts, a new feature that provides our clients with real-time updates on the latest impactful drug safety news. This is a project that our development and analyst teams have worked on diligently for the last three months, and I am excited to announce that it became a reality this week. 

Read More

Topics: Drug Safety, Clinical Trials, Evidex

Will 2017 Be The Year of Drug Safety?

Posted by Brian Overstreet on Jan 12, 2017 1:53:43 PM

On this past Sunday’s 60 Minutes, astronomer Mike Brown made a bold prediction – that within three years the scientific community would identity a new, large 9th planet located in the outermost area of our solar system.  Even more astonishing was how certain he was about that prediction, “I would say at this point, I am certain….that’s a rare thing to say – for a prediction for a scientist.  And I’m willing to say it.”  Mike Brown has some credibility in this area, as he’s the guy who figured out that Pluto wasn’t a planet after all.  Maybe it’s his own guilt over breaking every school-kid’s heart that’s driving his prediction, but both his prediction and his certainty really fascinated me.  If you haven’t watched the report, I’d urge you to do so (link is here).

Read More

Topics: Drug Safety

Working Toward a Cure: The Foundation for Sarcoidosis Research

Posted by Jim Davis on Jan 5, 2017 11:00:00 AM

In November 2016, I was honored to be asked to join the Board of Directors of the Foundation for Sarcoidosis Research (FSR). The foundation began in 1999 as a grassroots organization, and now has expanded their efforts and impact to become the leader in supporting sarcoidosis research. I'm looking forward to using my experiences both as a sarcoidosis patient and in drug safety to contribute to the mission. Please visit www.stopsarcoidosis.org for more information. 

I originally wrote the post below for the FSR blog. The original can be seen here

Read More

Topics: Drug Safety, sarcoidoisis

Top 10 Free Report Downloads of 2016

Posted by Jim Davis on Dec 29, 2016 11:00:00 AM

Thanks to all of our readers for a great 2016. Below is a top 10 countdown of Advera Health's most downloaded reports of the year with links to access the free downloads.

Read More

Top 10 Advera Health Blog Posts of 2016

Posted by Jim Davis on Dec 22, 2016 11:00:00 AM

Happy Holidays! Thanks to all of our readers for a great 2016. Below is a top 10 countdown of Advera Health's most read blog posts of the year with links to the full post. Enjoy.

Read More

Looking Ahead - Drug Safety in 2017

Posted by Brian Overstreet on Dec 16, 2016 11:00:00 AM

As 2016 winds down, am I the only one who feels exhausted? 

Between pharma-bro inspired drug pricing madness, a political season that felt like a Bravo reality TV show, and Leicester City robbing my beloved Tottenham Hotspur of their first shot at a Premiere League championship in a very long time, I think John Oliver summed up this year best in this video.

Read More

Topics: Drug Safety, Clinical Evidence, Evidex

How Memorial Hermann Uses an Evidence Aggregation Platform

Posted by Jim Davis on Dec 8, 2016 11:00:00 AM

Healthcare systems are generally slow to adopt new technologies. For all the talk about leveraging “Big Data,” the industry has been even slower to adopt analytics to make those data actionable. In fact, not one state Medicaid agency currently uses an evidence aggregation platform with post-approval adverse drug events intelligence when creating preferred drug lists, writing prior authorization criteria, negotiating supplemental rebates, educating prescribers and dispensers, or performing prospective, concurrent, or retrospective drug utilization reviews. This is in spite of the fact that millions of patient lives are put at risk and billions of dollars are spent every year from adverse drug events. Yet there is no mandate to use readily available, reliable data to inform making decisions about prescription medicines.

Fortunately there are the outliers - innovators and early adopters that see things differently. They know that they can make a difference by incorporating new ideas and approaches to improve patient outcomes and their own bottom lines.

Read More

Topics: RxCost, Evidex, memorial hermann, real world data, hospitals, evidence aggregation platform, cost of drug adverse events, IDN, health system, clinical trial results, adverse events

Mitigating Drug Litigation Risk with an Evidence Aggregation Platform

Posted by Jim Davis on Dec 1, 2016 11:00:00 AM

Product liability insurers protect pharmaceutical companies from legal actions associated with their drugs.  They have a significant economic incentive to scientifically assess and understand the scope of litigation risk.   Experienced underwriters use an evidence aggregation platform to better understand if a manufacturer’s drug is causing severe side effects that could lead to potential litigation. They also use an evidence aggregation platform to adopt and employ a simplified and unified process of assessing side effect risk with proven statistical measures via a simple interface that deploys in minutes.

Read More

Topics: Evidex, real world data, evidence aggregation platform, product liability, clinical trial results

Use Clinical Trial Results Linked to Real World Data for Better Formulary Reviews

Posted by Jim Davis on Nov 17, 2016 11:00:00 AM

Managed Care Organizations are reviewing drugs well before a product is approved. According to a survey conducted by Dymaxium (the company behind the AMCP eDossier System) and presented in a recent webinar, two out of three healthcare decision makers begin to evaluate a drug at least six months prior to approval. The survey also indicates that the primary source of information that payers are using for these pre-approval evaluations is clinicaltrials.gov (CT.gov), and that manufacturers are not always responsive to requests for information pre-approval.

Read More

Topics: Formulary, Drug Formulary, Evidex, real world data, evidence aggregation platform, clinical trial results, adverse events

When Things Go Right in Healthcare

Posted by Brian Overstreet on Nov 11, 2016 7:30:00 AM

In these blog posts we’re often guilty of highlighting the worst in healthcare (see, for example, here, here, and here).  That attitude shouldn’t be totally surprising when we started Advera Health Analytics with a mission to correct a glaring problem in the healthcare system – the lack of transparent drug safety and efficacy data.   That said, it seems only fair to give credit where it’s due when things go exactly right.  This is one of those stories.

Read More

Topics: healthcare

Subscribe to Email Updates